New Homocamptothecin Boosts Pancreatic Cancer Radiotherapy
In a groundbreaking study published in BMC Cancer, researchers have unveiled a promising new radiosensitizing agent, TOP-0618, a derivative of homocamptothecin, with significant potential to...